NDC properties for "sulindac 150 MG Oral Tablet" (RxCUI 198238)
About this data
The tables show NDC propoerties for sulindac 150 MG Oral Tablet with the RxCUI 198238
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for sulindac 150 MG Oral Tablet (RxCUI 198238)
| ANDA | ANDA071891 |
|---|---|
| ANDA | ANDA072050 |
| ANDA | ANDA072710 |
| ANDA | ANDA073262 |
| MMSL_CODE | BD3259 |
| MMSL_CODE | CD3259 |
| RxCUI | 198238 |
| SNOMEDCT | 375512001 |
| SPL_SET_ID | 0feabf47-8d0d-48c0-b263-43db4969f39e |
| SPL_SET_ID | 41c7882e-530a-4ac1-8de4-8d1e7b391467 |
| SPL_SET_ID | 89b01ca5-cfa5-4f5d-be6b-927d58cce0f2 |
| SPL_SET_ID | 96c73bd2-4577-487d-a642-bd8f91e94c3a |
| SPL_SET_ID | a47e4259-d44b-4b7b-b517-841cb6840982 |
| SPL_SET_ID | b906d325-27f1-4fb4-86ab-a2c896470e1e |
| SPL_SET_ID | d126f8a4-bc39-453c-bdd4-764ce4e1760d |
| SPL_SET_ID | d8b9d517-5dd4-4c6b-8aa0-736bce87e7b4 |
| SPL_SET_ID | eb7acb87-6565-4524-a91a-02064ea8bd1a |
| VUID | 4002974 |
| Prescribable Synonym | sulindac 150 MG Oral Tablet |
| RXNAV_STR | sulindac 150 MG Oral Tablet |
| RxNorm Name | sulindac 150 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 198238) |
NDC Properties
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 00378042701
| NDC 9 | 0378-0427 |
|---|---|
| NDC 10 | 0378-0427-01 |
| NDC Item | 00378042701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0427-01) |
| ANDA | ANDA073039 |
| COLORTEXT | YELLOW(yellow-orange) |
| Color | C48330 __ |
| FDA SPL set id | 571333 |
| Imprint code | MYLAN;427 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-31 |
| Marketing effective time low | 1993-06-22 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0427 |
NDC Item 00591566101
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-01 |
| NDC Item | 00591566101 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00591566105
| NDC 9 | 0591-5661 |
|---|---|
| NDC 10 | 0591-5661-05 |
| NDC Item | 00591566105 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) |
| ANDA | ANDA071891 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 712603 |
| Imprint code | DAN;5661 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-04-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0591-5661 |
NDC Item 00904621640
| NDC 9 | 0904-6216 |
|---|---|
| NDC 10 | 0904-6216-40 |
| NDC Item | 00904621640 |
| Packaging | 500 TABLET in 1 BOTTLE (0904-6216-40) |
| ANDA | ANDA072711 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 384832 |
| Imprint code | E10 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-06-30 |
| Marketing effective time low | 2010-11-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0904-6216 |
NDC Item 00904733460
| NDC 9 | 0904-7334 |
|---|---|
| NDC 10 | 0904-7334-60 |
| NDC Item | 00904733460 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) |
| ANDA | ANDA072050 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 721260 |
| Imprint code | MP;112 |
| Labeler | Major Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 0904-7334 |
NDC Item 23155000501
| NDC 9 | 23155-005 |
|---|---|
| NDC 10 | 23155-005-01 |
| NDC Item | 23155000501 |
| Packaging | 100 TABLET in 1 BOTTLE (23155-005-01) |
| ANDA | ANDA073262 |
| COLORTEXT | YELLOW(bright yellow) |
| Color | C48330 __ |
| FDA SPL set id | 73663 |
| Imprint code | HP;5 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2007-07-16 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 23155-005 |
NDC Item 24658077001
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-01 |
| NDC Item | 24658077001 |
| Packaging | 100 TABLET in 1 BOTTLE (24658-770-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 24658077005
| NDC 9 | 24658-770 |
|---|---|
| NDC 10 | 24658-770-05 |
| NDC Item | 24658077005 |
| Packaging | 500 TABLET in 1 BOTTLE (24658-770-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756082 |
| Imprint code | E10 |
| Labeler | PuraCap Laboratories LLC dba Blu Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-11-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 24658-770 |
NDC Item 42806001801
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-01 |
| NDC Item | 42806001801 |
| Packaging | 100 TABLET in 1 BOTTLE (42806-018-01) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001805
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-05 |
| NDC Item | 42806001805 |
| Packaging | 500 TABLET in 1 BOTTLE (42806-018-05) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 42806001810
| NDC 9 | 42806-018 |
|---|---|
| NDC 10 | 42806-018-10 |
| NDC Item | 42806001810 |
| Packaging | 1000 TABLET in 1 BOTTLE (42806-018-10) |
| ANDA | ANDA072710 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 756317 |
| Imprint code | E10 |
| Labeler | Epic Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 42806-018 |
NDC Item 52959019600
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-00 |
| NDC Item | 52959019600 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019610
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-10 |
| NDC Item | 52959019610 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019614
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-14 |
| NDC Item | 52959019614 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019615
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-15 |
| NDC Item | 52959019615 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019620
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-20 |
| NDC Item | 52959019620 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019630
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-30 |
| NDC Item | 52959019630 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 52959019660
| NDC 9 | 52959-196 |
|---|---|
| NDC 10 | 52959-196-60 |
| NDC Item | 52959019660 |
| Related queries | Properties for NDC 9 52959-196 |
NDC Item 53489047801
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-01 |
| NDC Item | 53489047801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047802
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-02 |
| NDC Item | 53489047802 |
| Packaging | 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047803
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-03 |
| NDC Item | 53489047803 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047805
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-05 |
| NDC Item | 53489047805 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047806
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-06 |
| NDC Item | 53489047806 |
| Packaging | 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 53489047810
| NDC 9 | 53489-478 |
|---|---|
| NDC 10 | 53489-478-10 |
| NDC Item | 53489047810 |
| Packaging | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 801157 |
| Imprint code | MP;112 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 53489-478 |
NDC Item 55289054130
| NDC 9 | 55289-541 |
|---|---|
| NDC 10 | 55289-541-30 |
| NDC Item | 55289054130 |
| Related queries | Properties for NDC 9 55289-541 |
NDC Item 63629496501
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-1 |
| NDC Item | 63629496501 |
| Packaging | 150 TABLET in 1 BOTTLE (63629-4965-1) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63629496502
| NDC 9 | 63629-4965 |
|---|---|
| NDC 10 | 63629-4965-2 |
| NDC Item | 63629496502 |
| Packaging | 60 TABLET in 1 BOTTLE (63629-4965-2) |
| ANDA | ANDA071891 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 126122 |
| Imprint code | DAN;5661 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2014-09-30 |
| Marketing effective time low | 1990-04-03 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 63629-4965 |
NDC Item 63874045001
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-01 |
| NDC Item | 63874045001 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045003
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-03 |
| NDC Item | 63874045003 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045012
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-12 |
| NDC Item | 63874045012 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045015
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-15 |
| NDC Item | 63874045015 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045020
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-20 |
| NDC Item | 63874045020 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 63874045030
| NDC 9 | 63874-450 |
|---|---|
| NDC 10 | 63874-450-30 |
| NDC Item | 63874045030 |
| Related queries | Properties for NDC 9 63874-450 |
NDC Item 66267026420
| NDC 9 | 66267-264 |
|---|---|
| NDC 10 | 66267-264-20 |
| NDC Item | 66267026420 |
| Related queries | Properties for NDC 9 66267-264 |
NDC Item 72789037301
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-01 |
| NDC Item | 72789037301 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |
NDC Item 72789037382
| NDC 9 | 72789-373 |
|---|---|
| NDC 10 | 72789-373-82 |
| NDC Item | 72789037382 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82) |
| ANDA | ANDA072050 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 810423 |
| Imprint code | MP;112 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-09-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 72789-373 |